Education
About Us
Working with TipRanks
Follow Us
AFLAC (AFL)
NYSE:AFL
AFL Stock Chart & Stats
Day’s Range― - ―
52-Week Range$80.59 - $115.50
Previous CloseN/A
Volume376.85K
Average Volume (3M)2.13M
Market Cap
$58.92B
Enterprise Value$64.96B
Total Cash (Recent Filing)$1.61B
Total Debt (Recent Filing)$2.58B
Price to Earnings (P/E)11.3
Beta0.46
Next Earnings
Apr 30, 2025EPS Estimate
1.67Last Dividend Ex-Date
Feb 19, 2025Dividend Yield1.91%
Share Statistics
EPS (TTM)9.61
Shares Outstanding545,814,600
10 Day Avg. Volume1,916,416
30 Day Avg. Volume2,134,456
Financial Highlights & Ratios
PEG Ratio0.47
Price to Book (P/B)N/A
Price to Sales (P/S)3.11
Price to Cash Flow (P/CF)44.40
P/FCF Ratio39.40
Enterprise Value/Market Cap1.10
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit3.40
Enterprise Value/Ebitda10.12
Forecast
1Y Price Target
$106.38Price Target Upside-1.45% Downside
Rating ConsensusHold
Number of Analyst Covering13
---
Bulls Say, Bears Say
Bulls Say
Capital PositionAFL's capital position remains strong, with significant buybacks and liquid assets above targets.
Product InnovationAFL is targeting younger consumers with a new 'first-sector' investment product to eventually support growth in its core 'third-sector' cancer and medical insurance offerings.
Underwriting MarginsThe strength in underwriting margins benefited from favorable remeasurement gains.
Bears Say
Earnings PerformanceAFL's 4Q:24 operating EPS and sales growth in Japan and the US missed expectations, raising concerns about its high P/E ratio.
Market DynamicsContinued growth headwinds are likely given competitive/secular dynamics in AFL's Japan and U.S. markets.
Sales Growth ChallengesSales growth in AFL Japan was significantly lower than expected, particularly due to weaker cancer product sales.
---
Ownership Overview
0.64% Insiders
13.06% Mutual Funds
10.40% Other Institutional Investors
54.22% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AFL FAQ
What was AFLAC’s price range in the past 12 months?
AFLAC lowest stock price was $80.59 and its highest was $115.50 in the past 12 months.
What is AFLAC’s market cap?
AFLAC’s market cap is $58.92B.
When is AFLAC’s upcoming earnings report date?
AFLAC’s upcoming earnings report date is Apr 30, 2025 which is in 3 days.
How were AFLAC’s earnings last quarter?
AFLAC released its earnings results on Feb 05, 2025. The company reported $1.56 earnings per share for the quarter, missing the consensus estimate of $1.623 by -$0.063.
Is AFLAC overvalued?
According to Wall Street analysts AFLAC’s price is currently Overvalued.
Does AFLAC pay dividends?
AFLAC pays a Quarterly dividend of $2.079 which represents an annual dividend yield of 1.91%. See more information on AFLAC dividends here
What is AFLAC’s EPS estimate?
AFLAC’s EPS estimate is 1.67.
How many shares outstanding does AFLAC have?
AFLAC has 545,814,600 shares outstanding.
What happened to AFLAC’s price movement after its last earnings report?
AFLAC reported an EPS of $1.56 in its last earnings report, missing expectations of $1.623. Following the earnings report the stock price went down -3.918%.
Which hedge fund is a major shareholder of AFLAC?
Currently, no hedge funds are holding shares in AFL
---
AFLAC Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$106.38 (-1.45% Downside)
$106.38 (-1.45% Downside)
Blogger Sentiment
Bullish
AFL Sentiment 83%
Sector Average 67%
Sector Average 67%
Hedge Fund Trend
Decreased
By 123.9K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $3.2M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▼ 0.3%
Last 30 Days ▲ 5.0%
Last 30 Days ▲ 5.0%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
31.59%
12-Months-Change
Fundamentals
Return on Equity
22.64%
Trailing 12-Months
Asset Growth
-10.30%
Trailing 12-Months
Company Description
AFLAC
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, nursing care income support, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan. The Aflac U.S. segment provides cancer, accident, short-term disability, critical illness, hospital indemnity, dental, vision, long-term care and disability, and term and whole life insurance products in the United States. It sells its products through sales associates, brokers, independent corporate agencies, individual agencies, and affiliated corporate agencies. The company was founded in 1955 and is based in Columbus, Georgia.
---
AFL Company Deck
---
AFL Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong overall performance with significant earnings growth and capital returns to shareholders. However, challenges were noted in the US sales, particularly in the dental segment, and in Japan's net earned premiums. The commercial real estate market also posed difficulties.Read More>---
AFL Stock 12 Month Forecast
Average Price Target
$106.38
▼(-1.45% Downside)
Technical Analysis
Best Analysts Covering AFL
1 Year
1 Year Success Rate
24/28 ratings generated profit
1 Year Average Return
+19.83%
reiterated a buy rating 25 days ago
Copying John Barnidge's trades and holding each position for 1 Year would result in 85.71% of your transactions generating a profit, with an average return of +19.83% per trade.
---